Adaptimmune Therapeutics PLC ADR: Istoricul versiunilor

29 septembrie 2024

• actualăprec 01:2929 septembrie 2024 01:29‎ 127.0.0.1 discuție‎ 1.292 de octeți +4‎ The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles). anulare

18 septembrie 2024

• actualăprec 15:3518 septembrie 2024 15:35‎ Admin discuție contribuții‎ 1.288 de octeți +1.288‎ Pagină nouă: Pagina dedicata companiei Adaptimmune Therapeutics PLC ADR listata cu simbolul US.ADAP ==Descriere companie== Adaptimmune Therapeutics plc (https://www.adaptimmune.com/) is a clinical-stage biopharmaceutical company that focuses on the development of novel cancer immunotherapy products for people with cancer. The Company’s Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple soli...